Literature DB >> 15948718

Analysis of bone mineral density in urolithiasis patients.

Hidenori Tsuji1, Tohru Umekawa, Takashi Kurita, Hirotsugu Uemura, Masanori Iguchi, Kokai Kin, Kazuhiro Kushida.   

Abstract

BACKGROUND: The association between hypercalciuria and bone mineral density (BMD) has been already recognized. The aim of the present study is to relate BMD to age and sex and to evaluate the calcium metabolism and hypercalciuria-defined dietary or non-dietary category in patients with urolithiasis.
METHODS: The BMI of the L2-L4 lumbar vertebrae was measured in 310 renal stone patients (191 men and 119 women). Percent age matched score (%AMS), which is the percent ratio of measured BMD to the mean BMD of age-matched control subjects, was utilized for the appraisal of BMD. Low BMD groups were defined by lower than 90% of %AMS.
RESULTS: Low BMD was observed in 27.7% of urinary stone patients, which was not a significant difference to that of control subjects (23.5%) who were measured in the health examination. In male patients with urolithiasis, the frequency of patients in whom BMD had been apt to decrease since youth was high, but there was not a proven significant difference among the three age groups (20-39 years old, 40-59 years old and 60 years old or older). In contrast, for female stone patients, the frequency of low BMD markedly increased in patients aged 40 years or older, when menopause occurs. Furthermore, in female stone patients with hypercalciuria, the frequency of reduced BMD reached more than 40%. When the cause was non-dietary hypercalciuria (classified mainly on the daily amount of urinary calcium excretion after ingestion of calculus test diet), the frequency of reduced BMD reached 65% (P < 0.01).
CONCLUSIONS: In case female stone patients with non-dietary hypercalciuria become menopausal, not only the risk of recurrent lithiasis increases, but the possibility of developing osteopenia in the future also increases. Appropriate treatments for prophylactic effects on urolithiasis or osteopenia should be considered, as judged from BMD, diet, sex, urinary calcium excretion and other factors synthetically.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15948718     DOI: 10.1111/j.1442-2042.2005.01049.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  11 in total

1.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

2.  The importance of calciuria as lithogenic factors in patients with osteopenia/osteoporosis.

Authors:  Miguel Arrabal-Martin; Antonio Poyatos-Andujar; María del Carmen Cano-García; Miguel Quesada-Charneco; Felix Abad-Menor; María Sierra Girón Prieto; Tomás de Haro Muñoz; Miguel Angel Arrabal-Polo
Journal:  Int Urol Nephrol       Date:  2015-02-05       Impact factor: 2.370

3.  UPDATE - Canadian Urological Association guideline: Evaluation and medical management of kidney stones.

Authors:  Naeem Bhojani; Jennifer Bjazevic; Brendan Wallace; Linda Lee; Kamaljot S Kaler; Marie Dion; Andrea Cowan; Nabil Sultan; Ben H Chew; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2022-06       Impact factor: 2.052

4.  Bone and metabolic markers in women with recurrent calcium stones.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Salvador Arias-Santiago
Journal:  Korean J Urol       Date:  2013-03-15

5.  Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  S C Kaste; N A Thomas; S N Rai; K Cheon; E McCammon; R Chesney; D Jones; C-H Pui; M M Hudson
Journal:  Leukemia       Date:  2008-10-02       Impact factor: 11.528

Review 6.  Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.

Authors:  P Lucato; C Trevisan; B Stubbs; B M Zanforlini; M Solmi; C Luchini; G Girotti; S Pizzato; E Manzato; G Sergi; S Giannini; M Fusaro; N Veronese
Journal:  Osteoporos Int       Date:  2016-06-11       Impact factor: 4.507

7.  Bone remodeling markers as lithogenic risk factors in patients with osteopenia-osteoporosis.

Authors:  María Sierra Girón-Prieto; Salvador Arias-Santiago; María Del Carmen Cano-García; Antonio Poyatos-Andújar; Tomás de Haro-Muñoz; Felix Abad-Menor; Miguel Quesada-Charneco; Miguel Ángel Arrabal-Polo; Miguel Arrabal-Martín
Journal:  Int Urol Nephrol       Date:  2016-07-04       Impact factor: 2.370

8.  Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia.

Authors:  Prasad L Gawade; Kirsten K Ness; Shelly Sharma; Zhenghong Li; Deo Kumar Srivastava; Sheri L Spunt; Kerri Nottage; Matthew J Krasin; Melissa M Hudson; Sue C Kaste
Journal:  J Cancer Surviv       Date:  2012-09-06       Impact factor: 4.442

9.  Incidence of osteoporosis in patients with urolithiasis.

Authors:  Radojka Bijelic; Snjezana Milicevic; Jagoda Balaban
Journal:  Med Arch       Date:  2014-10-15

10.  Correlation of Osteoporosis and Calcium Urolithiasis in Adult Population.

Authors:  Radojka Bijelic; Snjezana Milicevic; Jagoda Balaban
Journal:  Med Arch       Date:  2016-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.